A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aili He, MD, PhD
Second Affiliated Hospital of Xi 'an Jiaotong University
Principal Investigator - Baijun Fang, MD, PhD
Henan Tumor Hospital
Principal Investigator - Binghua Wang, MD, PhD
Weihai Central Hospital
Principal Investigator - Congmeng Lin, MD, PhD
Zhangzhou Hospital, Fujian Province
Principal Investigator - Da Gao, MD, PhD
The Affiliated Hospital of Inner Mongolia Medical University
Principal Investigator - Hongmei Jing, MD, PhD
Peking University Third Hospital
Principal Investigator - Huo Tan, MD, PhD
The First Affiliated Hospital of Guangzhou Medical University
Principal Investigator - Jianping Hao, MD, PhD
First Affiliated Hospital of Xinjiang Medical University
Principal Investigator - Jiao Chen, MD, PhD
Sichuan Provincial People's Hospital
Principal Investigator - Jie Jin, MD, PhD
The First Affiliated Hospital of Zhejiang University Medical College (Hematology)
Principal Investigator - Jinqiao Zhang, MD, PhD
Hebei Medical University Third Hospital
Principal Investigator - Juan Li, MD, PhD
First Affiliated Hospital, Sun Yat-Sen University
Principal Investigator - Junjun Li, MD, PhD
The First Affiliated Hospital of Nanhua University
Principal Investigator - Lihong Liu, MD, PhD
Hebei Medical University Fourth Hospital
Principal Investigator - Liping Su, MD, PhD
Shanxi Province Cancer Hospital
Principal Investigator - Ming Hou, MD, PhD
Shandong University Qilu Hospital
Principal Investigator - Qing Wang, MD, PhD
Guizhou Provincial People's Hospital
Principal Investigator - Quanyi Lu, MD, PhD
Zhongshan Hospital Xiamen University
Principal Investigator - Shunqing Wang, MD, PhD
Guangzhou First People's Hospital
Principal Investigator - Taiwu Xiao, MD, PhD
Liaocheng People's Hospital
Principal Investigator - Wei Wang, MD, PhD
The Affiliated Hospital of Qingdao University
Principal Investigator - Wei Yang, MD, PhD
Shengjing Hospital
Principal Investigator - Wenhong Lai, MD, PhD
The First Affiliated Hospital of Gannan Medical College
Principal Investigator - Wenming Chen, MD, PhD
Beijing Chao Yang Hospital
Principal Investigator - Xin Zhou, MD, PhD
Wuxi People's Hospital
Principal Investigator - Xuehong Ran, MD, PhD
Weifang People's Hospital
Principal Investigator - Xun Lai, MD, PhD
Yunnan Cancer Hospital
Principal Investigator - Yafei Wang, MD, PhD
Tianjin Cancer Hospital
Principal Investigator - Yanping Ma, MD, PhD
Second Hospital of Shanxi Medical University
Principal Investigator - Yanping Song, MD, PhD
Xi 'an Central Hospital
Principal Investigator - Ying Zhao, MD, PhD
First People's Hospital of Foshan
Principal Investigator - Zhen Cai, MD, PhD
The First Affiliated Hospital of Zhejiang University Medical College (Transplant Center)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Peking University Third Hospital
Beijing, Beijing Municipality, China
- Shengjing Hospital Affiliated To China Medical University
Beijing, Beijing Municipality, China
- Foshan First People'S Hospital
Foshan, Guangdong, China
- Guangzhou First People'S Hospital
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
- Guizhou Provincial People'S Hospital
Guiyang, Guizhou, China
- the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- the Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- Henan Tumor Hospital
Zhengzhou, Henan, China
- the First Affiliated Hospital of Nanhua University
Hengyang, Hunan, China
- Shandong University Qilu Hospital
Jinan, Shandong, China
- Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
- Weifang People'S Hospital
Weifang, Shandong, China
- Weihai Central Hospital
Weihai, Shandong, China
- Shanxi Cancer Hospital
Taiyuan, Shanxi, China
- the Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
- Second Affiliated Hospital of Xi 'An Jiaotong University
Xi’an, Shanxi, China
- Sichuan Provincial People'S Hospital
Chengdu, Sichuan, China
- Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, China
- Yunnan Cancer Hospital
Kunming, Yunnan, China
- the First Affiliated Hospital of Zhejiang University Medical College (hematology)
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jan 2021
- Primary completion
- 30 Jun 2022
- Completion
- 31 Dec 2023
- Last update posted
- 11 Feb 2022
- Registered enrollment
- 85
- Registry id
- NCT05236621
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.